EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata

Jung-Min Shin iD, Seungjin Son iD, Kyung Eun Jung iD, Chang Deok Kim iD, Young Lee iD

Experimental Dermatology · 2024

DOI: 10.1111/exd.15117 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Jung-Min Shin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Alopecia Areata, 3-Hydroxybutyric Acid, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alopecia areata (AA) is an autoimmune inflammatory disease characterized by non‐scarring hair loss due to an immune response that targets hair follicles. The current treatment approach for AA involves the use of immunosuppressants and immunomodulators to reduce cytokine levels around affected hair follicles. Sodium‐glucose cotransporter 2 (SGLT2) inhibitors have emerged as potential anti‐inflammatory agents with diverse beneficial effects in various medical conditions. This study investigates the role of beta‐hydroxybutyrate (BHB), a ketone body produced during SGLT2 inhibition, in the pathogenesis of AA. Serum BHB levels were found to be significantly elevated in patients with AA compared with healthy controls, with higher levels correlating with severity of hair loss. BHB treatment increased inflammatory cytokine production in outer root sheath (ORS) cells, mimicking the inflammatory conditions seen in AA. The results suggest that elevated BHB levels may exacerbate the inflammatory immune response in AA patients and may be associated with chronic hair loss and resistance to treatment. Serum BHB levels may serve as a potential marker of poor prognosis in patients with severe AA. Further research is needed to elucidate the precise role of BHB in the pathogenesis of AA and its implications for disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia Areata3-Hydroxybutyric AcidInflammationHumansAdultFemaleMaleCase-Control StudiesCytokinesHair FollicleYoung AdultMiddle Aged

Stichwörter der Autor:innen

alopecia areatainflammationβ‐hydroxybutyrate

Substanzen

3-Hydroxybutyric AcidCytokines

Autor:innen und Institutionen

  • Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Republic of Korea.

ORCID-Profile: Jung-Min Shin, Seungjin Son, Kyung Eun Jung, Chang Deok Kim, Young Lee

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Shin, J. M., Son, S., Jung, K. E., Kim, C. D., & Lee, Y. (2024). Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata. Experimental Dermatology. https://doi.org/10.1111/exd.15117

Vancouver

Shin JM, Son S, Jung KE, Kim CD, Lee Y. Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata. Experimental Dermatology. 2024. doi:10.1111/exd.15117

BibTeX
@article{Shin2024,
  author = {Shin, Jung-Min and Son, Seungjin and Jung, Kyung Eun and Kim, Chang Deok and Lee, Young},
  title = {Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata},
  journal = {Experimental Dermatology},
  year = {2024},
  doi = {10.1111/exd.15117}
}
Kostenlos starten →